15 Oct 2023 – EyRIS is thrilled to unveil a groundbreaking partnership with Mekdam Technology, one of Qatar’s premier technology conglomerates. This partnership introduces cutting-edge AI screening tools to accelerate early detection of medical conditions. The first AI to be introduced is SELENA+ which uncover eye diseases namely diabetic retinopathy, glaucoma and age-related macular degeneration.
Additional AI algorithms will follow suit to facilitate the identification of chronic diseases such as cardiovascular and renal conditions. The deployment of multiple of deeptech innovations on a single platform promises to make a significant impact on healthcare outcomes in Qatar.
EyRIS provides a cloud-based platform utilizing deep learning to analyze retinal images and provide rapid screening results diabetic-related eye diseases and chronic conditions. With accuracy and speed of detection, our flagship product SELENA+ makes mass eye screening possible at primary care level, thereby identifying patients that need urgent attention. SELENA+ has been rigorously validated in numerous clinical studies and holds regulatory approvals in amongst other places Singapore, Europe and Australia.
For more 25 years, Mekdam Technology has been implementing and various integrating technologies in large-scale projects in Qatar. As a partner with extensive local experience, Mekdam is a perfect match to deliver our vision. With their support, we are confident that this partnership will not only succeed but also bring profound benefits to the people of Qatar.
Please direct all queries related to this article to Marketing at enquiry@nova-hub.com
Comments are closed.